Literature DB >> 21415125

Feasibility of contrast-enhanced and nonenhanced MRI for intraprocedural and postprocedural lesion visualization in interventional electrophysiology: animal studies and early delineation of isthmus ablation lesions in patients with typical atrial flutter.

Peter Nordbeck1, Karl-Heinz Hiller, Florian Fidler, Marcus Warmuth, Natalie Burkard, Matthias Nahrendorf, Peter M Jakob, Harald H Quick, Georg Ertl, Wolfgang R Bauer, Oliver Ritter.   

Abstract

BACKGROUND: Imaging of myocardial ablation lesions during electrophysiology procedures would enable superior guidance of interventions and immediate identification of potential complications. The aim of this study was to establish clinically suitable MRI-based imaging techniques for intraprocedural lesion visualization in interventional electrophysiology. METHODS AND
RESULTS: Interventional electrophysiology was performed under magnetic resonance guidance in an animal model, using a custom setup including magnetic resonance-conditional catheters. Various pulse sequences were explored for intraprocedural lesion visualization after radiofrequency ablation. The developed visualization techniques were then used to investigate lesion formation in patients immediately after ablation of atrial flutter. The animal studies in 9 minipigs showed that gadolinium-DTPA-enhanced T1-weighted and nonenhanced T2-weighted pulse sequences are particularly suitable for lesion visualization immediately after radiofrequency ablation. MRI-derived lesion size correlated well with autopsy (R(2)=0.799/0.709 for contrast-enhanced/nonenhanced imaging). Non-contrast agent-enhanced techniques were suitable for repetitive lesion visualization during electrophysiological interventions, thus allowing for intraprocedural monitoring of ablation success. The patient studies in 24 patients with typical atrial flutter several minutes to hours after cavotricuspid isthmus ablation confirmed the results from the animal experiments. Therapeutic lesions could be visualized in all patients using contrast-enhanced and also nonenhanced MRI with high contrast-to-noise ratio (94.6±35.2/111.1±32.6 versus 48.0±29.0/68.0±37.3 for ventricular/atrial lesions and contrast-enhanced versus nonenhanced imaging).
CONCLUSIONS: MRI allows for precise lesion visualization in electrophysiological interventions just minutes after radiofrequency ablation. Nonenhanced T2-weighted MRI is particularly feasible for intraprocedural delineation of lesion formation as lesions are detectable within minutes after radiofrequency delivery and imaging can be repeated during interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415125     DOI: 10.1161/CIRCIMAGING.110.957670

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  12 in total

Review 1.  Catheter ablation guided by real-time MRI.

Authors:  Charlotte Eitel; Gerhard Hindricks; Matthias Grothoff; Matthias Gutberlet; Philipp Sommer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

2.  Cardiac Electrophysiology Under MRI Guidance: an Emerging Technology.

Authors:  Henry Chubb; Steven E Williams; John Whitaker; James L Harrison; Reza Razavi; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 3.  Role of Cardiac Imaging (CT/MR) Before and After RF Catheter Ablation in Patients with Atrial Fibrillation.

Authors:  Aravindan Kolandaivelu
Journal:  J Atr Fibrillation       Date:  2012-08-20

4.  Direct cooling of the catheter tip increases safety for CMR-guided electrophysiological procedures.

Authors:  Theresa Reiter; Daniel Gensler; Oliver Ritter; Ingo Weiss; Wolfgang Geistert; Ralf Kaufmann; Sabine Hoffmeister; Michael T Friedrich; Stefan Wintzheimer; Markus Düring; Peter Nordbeck; Peter M Jakob; Mark E Ladd; Harald H Quick; Wolfgang R Bauer
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

Review 5.  Update on atrial fibrillation catheter ablation technologies and techniques.

Authors:  Jane Dewire; Hugh Calkins
Journal:  Nat Rev Cardiol       Date:  2013-08-27       Impact factor: 32.419

6.  Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: a histological validation study.

Authors:  James L Harrison; Henrik K Jensen; Sarah A Peel; Amedeo Chiribiri; Anne K Grøndal; Lars Ø Bloch; Steen F Pedersen; Jacob F Bentzon; Christoph Kolbitsch; Rashed Karim; Steven E Williams; Nick W Linton; Kawal S Rhode; Jaswinder Gill; Michael Cooklin; C A Rinaldi; Matthew Wright; Won Y Kim; Tobias Schaeffter; Reza S Razavi; Mark D O'Neill
Journal:  Eur Heart J       Date:  2014-01-12       Impact factor: 29.983

Review 7.  The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia.

Authors:  Riccardo Proietti; Luca Lichelli; Nicolas Lellouche; Tarvinder Dhanjal
Journal:  J Arrhythm       Date:  2020-12-28

8.  Fast myocardial T mapping in mice using k-space weighted image contrast and a Bloch simulation-optimized radial sampling pattern.

Authors:  Maximilian Gram; Daniel Gensler; Patrick Winter; Michael Seethaler; Paula Anahi Arias-Loza; Johannes Oberberger; Peter Michael Jakob; Peter Nordbeck
Journal:  MAGMA       Date:  2021-09-07       Impact factor: 2.310

9.  Quantification correction for free-breathing myocardial T mapping in mice using a recursively derived description of a T* relaxation pathway.

Authors:  Maximilian Gram; Daniel Gensler; Petra Albertova; Fabian Tobias Gutjahr; Kolja Lau; Paula-Anahi Arias-Loza; Peter Michael Jakob; Peter Nordbeck
Journal:  J Cardiovasc Magn Reson       Date:  2022-05-09       Impact factor: 6.903

10.  Cardiovascular magnetic resonance guided ablation and intra-procedural visualization of evolving radiofrequency lesions in the left ventricle.

Authors:  Philippa R P Krahn; Sheldon M Singh; Venkat Ramanan; Labonny Biswas; Nicolas Yak; Kevan J T Anderson; Jennifer Barry; Mihaela Pop; Graham A Wright
Journal:  J Cardiovasc Magn Reson       Date:  2018-03-15       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.